The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 9, Pages e25264
Publisher
Public Library of Science (PLoS)
Online
2011-09-30
DOI
10.1371/journal.pone.0025264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression
- (2011) A. E. Rose et al. CANCER RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway
- (2011) A E Thurber et al. ONCOGENE
- Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
- (2011) Y Cheli et al. ONCOGENE
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
- (2010) D Handolias et al. BRITISH JOURNAL OF CANCER
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
- (2010) Elsa Quintana et al. CANCER CELL
- Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma Phenotype
- (2010) K. M. Hardy et al. CANCER RESEARCH
- -Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
- (2010) C. A. Gilbert et al. CANCER RESEARCH
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma
- (2010) H.-H. Chang et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Progress in understanding melanoma propagation
- (2010) Mark Shackleton et al. Molecular Oncology
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
- (2010) Koos E. Hovinga et al. STEM CELLS
- Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
- (2009) Chelsea C. Pinnix et al. CANCER RESEARCH
- Preclinical Profile of a Potent -Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
- (2009) L. Luistro et al. CANCER RESEARCH
- Mechanism of Drug Sensitivity and Resistance in Melanoma
- (2009) Caterina La Porta CURRENT CANCER DRUG TARGETS
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
- (2009) D. Bogunovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
- (2008) Adam I Riker et al. BMC Medical Genomics
- Melanoma epidemiology and trends
- (2008) Claus Garbe et al. CLINICS IN DERMATOLOGY
- Notch1 is an effector of Akt and hypoxia in melanoma development
- (2008) Barbara Bedogni et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- Role of nodal signaling and the microenvironment underlying melanoma plasticity
- (2008) Lynne-Marie Postovit et al. Pigment Cell & Melanoma Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started